FINANCIALS

NAMS Newamsterdam Pharma Co Nv 1936258

Income Statement
Revenue	nams-20241231	45,563,000
Net Income	nams-20241231	-241,598,000
Profit Margin		-530.25%

Balance Sheet
Current Assets	863,413,000
Assets	864,620,000
Current Liabilities	106,918,000
Liabilities	107,120,000
Equity	757,500,000
Shares Out	90,015,000

Cash Flow Statement
Operating Cash Flow	-158,564,000
Investing Cash Flow	-62,848,000

Market Analysis
Market Cap	1,417,741,762
Price	24.21
BVPS	8.42
PB	2.79
EPS	-2.64
PS	7.78
FCF	-221,412,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view NAMS documents filed with the SEC.

NAMS Filings Clear

View A List of Tickers